Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products

A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (July 1, 2026 through July 31, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a .... Read More

 A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (July 3, 2026 through July 31, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a .... Read More

A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (July 1, 2026 through July 31, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a .... Read More

The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at the National
Center for Advancing Translational Sciences (NCATS) conducts translational research in the area of human
therapeutics development. 

The scope of this contract is for Chemistry, Manufacturing, and Control (CMC) services for Drug Products. The
objective of these support services is to ensure receipt of formulated Drug Product (DP) of sufficient quality and quantity to support preclinical, IND-enabling and clinical studies.

The Contractor shall provide support for a broad range of preclinical services required for the design, development,
.... Read More

The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at the National
Center for Advancing Translational Sciences (NCATS) conducts translational research in the area of human
therapeutics development. 

The scope of this contract is for Chemistry, Manufacturing, and Control (CMC) services for Drug Products. The
objective of these support services is to ensure receipt of formulated Drug Product (DP) of sufficient quality and quantity to support preclinical, IND-enabling and clinical studies.

The Contractor shall provide support for a broad range of preclinical services required for the design, development,
.... Read More